Type 1 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been clinically diagnosed with type 1 diabetes for 5 or more years.
• People who use an insulin pump (either a standard manual pump or a hybrid closed-loop/automated system) and have not changed their treatment method in the past 2 or more months, and are willing to share their continuous glucose monitor (CGM) data with the research team.
• People who use rapid-acting or ultra-rapid-acting insulin (such as Aspart, Lispro, Glulisine, or FiAsp).
• People whose HbA1c (a measure of average blood sugar over roughly 3 months) is between 7.0% and 9.9%.
• People with a Body Mass Index (BMI) of 25 or above.
• People whose waist measurement meets the central obesity thresholds set by Diabetes Canada — specifically: 94cm or more for males of European, Sub-Saharan African, Eastern Mediterranean, or Middle Eastern descent; 90cm or more for males of South Asian, Chinese, Japanese, or South and Central American descent; and 80cm or more for females.
• People with no history of stroke, heart attack, or coronary artery disease.
• People who do not have any implanted medical devices (such as pacemakers, neurostimulators, cochlear implants, stents, or similar devices — confirm full list with trial site).
• People who already use a CGM as part of their regular diabetes management.

Who may not be able to join:

• People who have had a major diabetes-related or cardiovascular complication in the past 3 months, such as a severe low blood sugar episode requiring help from another person, diabetic ketoacidosis, or a cardiovascular event.
• People who are unable to do aerobic or resistance exercise due to significant diabetes complications (such as severe nerve damage or active eye disease) or other physical limitations (such as serious joint or bone conditions).
• People with uncontrolled high blood pressure (above 160 mmHg systolic or above 100 mmHg diastolic).
• People with an implanted device, implanted material, or a medical condition that makes MRI scanning unsafe (confirm with trial site).
• People who are currently pregnant or breastfeeding.
• People who are unable to give informed consent.
• People who manage their insulin using injections rather than a pump (for example, multiple daily injections, or a combination of pump and injection-based delivery).

Important: Always verify eligibility with the trial site directly before applying.